NTx-488

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNTx-488
Drug Alias NameNTx-488
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCell differentiation stimulantsOvarian follicle stimulantsErythropoietin receptor agonists
TargetsProlactin receptorErythropoietin receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrillium Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrillium Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A